No need to forego cooling when you need compression.
Explore the source record for details and available documents.
Biomedical subjects
Publications and source records attributed to Cyrus Chess.
Explore the source record for details and available documents.
OBJECTIVE: To evaluate the Polaris LV, electro-optical synergy (ELOS) technology, which combines diode laser (915 nm) and radiofrequency (RF) (1 MHz) energies, for the treatment of leg veins. METHODS: A total of 25 patients (Fitzpatrick I-IV) with a total of 35 sites (0.3-5.0 mm vessel diameters) were treated with up to three sessions at 4- to 10-week intervals. Polaris LV settings included: 80-140 J/cm(2) of laser light, 80-100 J/cm(3) of conducted RF, and pulses of 100-300 ms. Vessel clearance was graded by both the treating and an independent physician. RESULTS: At 1 and 6 months after the final treatment, approximately 77% of treatment sites exhibited 75-100% vessel clearance, and 90% had 50-100% vessel clearance. No treatment sites had less than 25% vessel clearance. Transient dyschromic side effects were common. CONCLUSIONS: The Polaris LV ELOS system is effective and safe in treating leg veins, including telangiectases, venulectases, and reticular veins.